Microbial hydroxylation of ML-236B (compactin). Studies on microorganisms capable of 3 beta-hydroxylation of ML-236B - PubMed (original) (raw)

Comparative Study

Microbial hydroxylation of ML-236B (compactin). Studies on microorganisms capable of 3 beta-hydroxylation of ML-236B

N Serizawa et al. J Antibiot (Tokyo). 1983 Jul.

Free article

Abstract

Various microorganisms were tested for capability to hydroxylate of ML-236B at the 3 beta-position. As the result, it was found that this ability was limited to a small group of microorganisms, mainly Zygomycetes in fungi, and Nocardia in actinomycetes.

PubMed Disclaimer

Similar articles

• Taxonomy of actinomycetes capable of hydroxylation of ML-236B (compactin).
  Okazaki T, Serizawa N, Enokita R, Torikata A, Terahara A. Okazaki T, et al. J Antibiot (Tokyo). 1983 Sep;36(9):1176-83. doi: 10.7164/antibiotics.36.1176. J Antibiot (Tokyo). 1983. PMID: 6630076
• 6 alpha-Hydroxy-iso-ML-236B (6 alpha-hydroxy-iso-compactin) and ML-236A, microbial transformation products of ML-236B.
  Serizawa N, Nakagawa K, Tsujita Y, Terahara A, Kuwano H, Tanaka M. Serizawa N, et al. J Antibiot (Tokyo). 1983 Jul;36(7):918-20. doi: 10.7164/antibiotics.36.918. J Antibiot (Tokyo). 1983. PMID: 6549610 No abstract available.
• 3 alpha-Hydroxy-ML-236B (3 alpha-hydroxycompactin), microbial transformation product of ML-236B (compactin).
  Serizawa N, Nakagawa K, Tsujita Y, Terahara A, Kuwano H. Serizawa N, et al. J Antibiot (Tokyo). 1983 May;36(5):608-10. doi: 10.7164/antibiotics.36.608. J Antibiot (Tokyo). 1983. PMID: 6874578 No abstract available.
• Microbial aromatization of steroids.
  Vézina C, Sehgal SN, Singh K, Kluepfel D. Vézina C, et al. Prog Ind Microbiol. 1971;10:1-47. Prog Ind Microbiol. 1971. PMID: 4945410 Review. No abstract available.
• [Regulation of cholesterol synthesis, as focused on the regulation of HMG-CoA reductase (author's transl)].
  Endo A. Endo A. Seikagaku. 1980 Oct;52(10):1033-49. Seikagaku. 1980. PMID: 7017025 Review. Japanese. No abstract available.

Cited by

• Fermentative production and optimization of mevastatin in submerged fermentation using Aspergillus terreus.
  Syed MB, Rajasimman M. Syed MB, et al. Biotechnol Rep (Amst). 2015 Apr 9;6:124-128. doi: 10.1016/j.btre.2015.04.002. eCollection 2015 Jun. Biotechnol Rep (Amst). 2015. PMID: 28435810 Free PMC article.
• Single-step fermentative production of the cholesterol-lowering drug pravastatin via reprogramming of Penicillium chrysogenum.
  McLean KJ, Hans M, Meijrink B, van Scheppingen WB, Vollebregt A, Tee KL, van der Laan JM, Leys D, Munro AW, van den Berg MA. McLean KJ, et al. Proc Natl Acad Sci U S A. 2015 Mar 3;112(9):2847-52. doi: 10.1073/pnas.1419028112. Epub 2015 Feb 17. Proc Natl Acad Sci U S A. 2015. PMID: 25691737 Free PMC article.
• Identification and characterization of Penicillium citrinum VeA and LaeA as global regulators for ML-236B production.
  Baba S, Kinoshita H, Nihira T. Baba S, et al. Curr Genet. 2012 Feb;58(1):1-11. doi: 10.1007/s00294-011-0359-x. Epub 2011 Dec 24. Curr Genet. 2012. PMID: 22198576
• A fungal family of transcriptional regulators: the zinc cluster proteins.
  MacPherson S, Larochelle M, Turcotte B. MacPherson S, et al. Microbiol Mol Biol Rev. 2006 Sep;70(3):583-604. doi: 10.1128/MMBR.00015-06. Microbiol Mol Biol Rev. 2006. PMID: 16959962 Free PMC article. Review.
• Screening of compactin-resistant microorganisms capable of converting compactin to pravastatin.
  Chen CH, Hu HY, Cho YC, Hsu WH. Chen CH, et al. Curr Microbiol. 2006 Aug;53(2):108-12. doi: 10.1007/s00284-005-0276-7. Epub 2006 Jun 26. Curr Microbiol. 2006. PMID: 16802209

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • J-STAGE, Japan Science and Technology Information Aggregator, Electronic

• Other Literature Sources

  • The Lens - Patent Citations

• Medical

  • MedlinePlus Health Information

• Research Materials

  • NCI CPTC Antibody Characterization Program